Home > Healthcare > Medical Devices > Diagnostic Devices > Pyrogen Testing Market

Pyrogen Testing Market Trends

  • Report ID: GMI8867
  • Published Date: Apr 2024
  • Report Format: PDF

Pyrogen Testing Market Trends

Increased research and development (R&D) investment often leads to the development of cutting-edge technologies and methodologies. In the realm of pyrogen testing this translates to the emergence of more sensitive, specific, and efficient testing techniques. Advanced analytical instruments, novel assay platforms, and innovative approaches may enhance the accuracy and reliability of pyrogen detection, thereby improving the overall safety assessment of pharmaceutical products.

  • For instance, in 2022, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported an investment of approximately USD 48.65 billion in research and development (R&D) in Europe.
  • R&D efforts focused on pyrogen testing can refine assays to detect trace amounts of pyrogens with heightened sensitivity. This sensitivity is critical especially for ensuring the safety of biopharmaceuticals and medical devices, as even minute levels of pyrogens can pose significant risks to patients.
  • The innovations stemming from R&D investments may streamline pyrogen testing procedures reducing the time required for analysis. Rapid testing methods enable expedited release of pharmaceutical batches, facilitating quicker product availability to meet market demands without compromising safety.
  • Further, R&D efforts in pyrogen testing can yield cost-effective solutions through protocol optimization, efficient technologies, and minimized resource consumption, benefiting pharmaceutical manufacturers without compromising safety standards, thereby escalating the growth of the market.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size for pyrogen testing was valued at USD 1.3 billion in 2023 and is estimated to reach over USD 2.8 billion by 2032, attributed to increasing prevalence of chronic disease diseases, including cardiovascular diseases, diabetes, and cancer.

The LAL test segment in the pyrogen testing market accounted for USD 580.2 million in 2023, as this test provides rapid results with most assays yielding quantitative data within a few hours.

North America market size was USD 530.3 million in 2023, as state-of-the-art facilities and equipment enable accurate, reliable, and efficient detection of pyrogens in pharmaceutical products.

Almac Group, bioMérieux SA, Charles River Laboratories International, Inc., Eurofins Scientific, Fujifilm Holdings Corporation, GenScript Biotech Corporation, Lonza, Merck KGaA, STERIS plc and Thermo Fisher Scientific Inc.

Pyrogen Testing Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 226
  • Countries covered: 22
  • Pages: 190
 Download Free Sample